Point-of-care NT-proBNP monitoring for heart failure: observational feasibility study in primary care
<strong>Background </strong>Around one million individuals in the UK have heart failure (HF), a chronic disease that causes significant morbidity and mortality. N-terminal pro–B-type natriuretic peptide (NT-proBNP) monitoring could help improve the care of patients with HF in the communi...
Asıl Yazarlar: | Chami, J, Fleming, S, Taylor, C, Bankhead, C, James, T, Shine, B, McLellan, J, Hobbs, FDR, Perera, R |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
Royal College of General Practitioners
2022
|
Benzer Materyaller
-
Point-of-care NT-proBNP monitoring for heart failure: observational feasibility study in primary care
Yazar:: Jason Chami, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01) -
The integration of BNP and NT-proBNP into clinical medicine
Yazar:: Swiss Medical Weekly
Baskı/Yayın Bilgisi: (2007-01-01) -
Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors
Yazar:: Hussein Alawieh, ve diğerleri
Baskı/Yayın Bilgisi: (2019-11-01) -
BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
Yazar:: Robert A. Lewis, ve diğerleri
Baskı/Yayın Bilgisi: (2020-05-01) -
A Point-of-Care Measurement of NT-proBNP for Heart Failure Patients
Yazar:: Cesar Navarro, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)